RESUMO
Correctional facilities house millions of residents in communities throughout the United States. Such congregate settings are critical for national infection prevention and control (IPC) efforts. Carceral settings can be sites where infectious diseases are detected in patient populations who may not otherwise have access to health care services, and as highlighted by the COVID-19 pandemic, where outbreaks of infectious diseases may result in spread to residents, correctional staff, and the community at large. Correctional IPC, while sharing commonalities with IPC in other settings, is unique programmatically and operationally. In this article, we identify common challenges with correctional IPC program implementation and recommend action steps for advancing correctional IPC as a national public health priority.
Assuntos
COVID-19 , Doenças Transmissíveis , Humanos , Estados Unidos/epidemiologia , Prisões , Pandemias/prevenção & controle , COVID-19/epidemiologia , COVID-19/prevenção & controle , Controle de InfecçõesRESUMO
The American College of Physicians (ACP) has a long-standing commitment to improving the health of all Americans and opposes any form of discrimination in the delivery of health care services. ACP is committed to working toward fully understanding and supporting the unique needs of the incarcerated population and eliminating health disparities for these persons. In this position paper, ACP offers recommendations to policymakers and administrators to improve the health and well-being of persons incarcerated in adult correctional facilities.
Assuntos
Médicos , Prisioneiros , Adulto , Humanos , Estados Unidos , Prisões , Atenção à Saúde , Políticas , Política de SaúdeRESUMO
As the United States wrestles with the consequences of the COVID-19 pandemic and concurrently confronts long-standing issues of racial injustice, it is more important than ever that criminal justice health becomes an integrated component of medical school curricula. Nearly all future physicians will someday be caring for justice-involved patients or their family members. A foundational medical school education that includes criminal justice health will better equip these physicians to not only care for their patients, but also help address health care disparities and the public health concerns that affect our communities. These recommended changes to U.S. medical school curricula will occur only with the commitment of academic leaders and their inclusion of medical school faculty with criminal justice health expertise to help guide these efforts. Now is the time for U.S. medical schools to embrace criminal justice health as essential learning.
Assuntos
COVID-19 , Estudantes de Medicina , Direito Penal , Currículo , Educação em Saúde , Humanos , Pandemias , SARS-CoV-2 , Faculdades de Medicina , Estados UnidosRESUMO
Transgender persons are at increased risk of victimization during incarceration and have unique health care needs. We convened a symposium of 27 key stakeholders to develop consensus on correctional policy, practice, and clinical care considerations for incarcerated transgender persons. Participants included formerly justice-involved transgender persons, correctional leaders, government authorities, academicians, advocates, health care providers, and expert consultants. Consensus considerations were developed in four areas: correctional practices that promote safety and respectful interactions with transgender inmates, training of correctional staff, health care delivery, and reentry to the community. Gaps in knowledge and practice in these four areas were also identified. A collaborative stakeholder model is an effective strategy to convene disparate groups who infrequently communicate with one another to help advance correctional policies and clinical care.
Assuntos
Formulação de Políticas , Prisões/organização & administração , Pessoas Transgênero , Comportamento Cooperativo , Humanos , Relações Interinstitucionais , Prisões/normas , Participação dos InteressadosRESUMO
CONTEXT: Correctional facilities provide unique opportunities to diagnose and treat persons with latent tuberculosis infection (LTBI). Studies have shown that 12 weekly doses of isoniazid and rifapentine (INH-RPT) to treat LTBI resulted in high completion rates with good tolerability. OBJECTIVE: To evaluate completion rates and clinical signs or reported symptoms associated with discontinuation of 12 weekly doses of INH-RPT for LTBI treatment. SETTING/PARTICIPANTS: During July 2012 to February 2015, 7 Federal Bureau of Prisons facilities participated in an assessment of 12 weekly doses of INH-RPT for LTBI treatment among 463 inmates. MAIN OUTCOME MEASURES: Fisher exact test was used to assess the associations between patient sociodemographic characteristics and clinical signs or symptoms with discontinuation of treatment. RESULTS: Of 463 inmates treated with INH-RPT, 424 (92%) completed treatment. Reasons for discontinuation of treatment for 39 (8%) inmates included the following: 17 (44%) signs/symptoms, 9 (23%) transfer or release, 8 (21%) treatment refusal, and 5 (13%) provider error. A total of 229 (49.5%) inmates reported experiencing at least 1 sign or symptom during treatment; most frequently reported were fatigue (16%), nausea (13%), and abdominal pain (7%). Among these 229 inmates, signs/symptoms significantly associated with discontinuation of treatment included abdominal pain (P < .001), appetite loss (P = .02), fever/chills (P = .01), nausea (P = .03), sore muscles (P = .002), and elevation of liver transaminases 5× upper limits of normal or greater (P = .03). CONCLUSIONS: The LTBI completion rates were high for the INH-RPT regimen, with few inmates discontinuing because of signs or symptoms related to treatment. This regimen also has practical advantages to aid in treatment completion in the correctional setting and can be considered a viable alternative to standard LTBI regimens.
Assuntos
Isoniazida/uso terapêutico , Tuberculose Latente/tratamento farmacológico , Adesão à Medicação/estatística & dados numéricos , Prisões/estatística & dados numéricos , Rifampina/análogos & derivados , Adulto , Antituberculosos/uso terapêutico , Terapia Diretamente Observada/métodos , Terapia Diretamente Observada/normas , Terapia Diretamente Observada/estatística & dados numéricos , Feminino , Humanos , Tuberculose Latente/psicologia , Masculino , Pessoa de Meia-Idade , Mycobacterium/efeitos dos fármacos , Mycobacterium/patogenicidade , Projetos Piloto , Estudos Prospectivos , Rifampina/uso terapêuticoRESUMO
We assessed the performance of a recently validated real-time PCR assay and a commercially available microimmunofluorescence serologic test for the detection of Chlamydophila pneumoniae infection during an outbreak. Evaluation of specimens from 137 individuals suggests that real-time PCR holds greater utility as a diagnostic tool for early C. pneumoniae detection.